{
  "hash": "b095366491ada91ce1cc593f92843951",
  "result": {
    "engine": "knitr",
    "markdown": "---\ntitle: \"Neuroimaging in Pediatric Epilepsy\"\nauthor: Maksim Parfyonov MD, FRCPC\ninstitute: Cleveland Clinic Epilepsy Center\nsubtitle: \"EEG Course 2024\"\ndate: 2024-08-09\nformat: revealjs\nlogo: logo.png\ncss: logo.css\nbibliography: refs.bib\ncsl: epilepsia.csl\n---\n\n\n## Discolosures\n\nNone\n\n## Objectives\n\n1.  Imaging basics and modalities\n2.  Review indications for neuroimaging in pediatric epilepsy\n3.  Imaging guidelines suggested by ILAE\n4.  Overview of common and less common substrates for epilepsy\n\n## Neuroimaging basics\n\n![](planes.png)\n\n## Imaging modalities in epilepsy\n\n-   Structural: CT, MRI\n-   Functional: fMRI, PET, SPECT\n-   Advanced post-processing techniques (e.g. VBM), novel methodology (MRF)\n\n# MRI Basics\n\n## What are we actually measuring?\n\n![](mr-physics1.jpg) [@broadhouse_2019]\n\n## \"Relaxation\"\n\n::: columns\n::: column\n![](mr-phys3.gif)[^1]\n:::\n\n::: column\n![](mr-phys4.gif)\n:::\n:::\n\n[^1]: Courtesy of Allen D. Elster, MRIquestions.com\n\n## T1 vs T2\n\n::: columns\n::: column\n![](mr-phys5.gif)\n:::\n\n::: column\n![](mr-phys6.gif)[^2]\n:::\n:::\n\n[^2]: Courtesy of Allen D. Elster, MRIquestions.com\n\n## Signal Detection\n\n![](mr-physics2.png)\n\n-   More than you ever wanted to know about [MRI physics](https://mriquestions.com/index.html)\n\n## T1 vs T2-weighted images\n\n![](t1_t2_flair.webp) \n\nCourtesy of [Preston, 2016](https://case.edu/med/neurology/NR/MRI%20Basics.html)\n\n# Why is imaging important in epilepsy?\n\n## Reasons for Neuroimaging \n\n:::{.incremental}\n-   establish etiology\n-   prognosis\n-   identify an acute process, e.g. hydrocephalus, encephalitis\n-   subacute or chronic process that requires intervention e.g. tumor, or has other prognostic implications, e.g. leukodystrophy\n-   focal lesions may be potentially amenable to epilepsy surgery e.g. MCD\n:::\n\n## Finding a lesion\n::: {.incremental}\n- Epilepsy surgery success is directly related to precise localization of EZ [@Blume_1986]\n- Rate of success in lesional TLE 62-80% vs nonlesional 36% [@Berkovic_etal1995]\n- Meta-analysis of 40 articles and 697 NL and 2860 LE patients: SZ free odds increased with lesional 2.5 overall, 2.7 temporal and 2.9 extratemporal [@tellez-zenteno.etal2010]\n:::\n\n## Approach to Epilespy Surgery\n\n\n::: {.cell}\n::: {.cell-output-display}\n\n```{=html}\n<div class=\"grViz html-widget html-fill-item\" id=\"htmlwidget-3589b03550fef1266f7d\" style=\"width:960px;height:480px;\"></div>\n<script type=\"application/json\" data-for=\"htmlwidget-3589b03550fef1266f7d\">{\"x\":{\"diagram\":\"\\ndigraph flowchart {\\n  # Node definitions with substituted label text\\n  node [fontname = Helvetica, shape = rectangle, fontsize = 20, style = filled]\\n  tab1 [label = \\\"Treatment-resistant epilepsy\\\", fillcolor = white]\\n  tab2 [label = \\\"VEEG\\\", fillcolor = white, shape = ellipse]\\n  tab3 [label = \\\"Focal\\\", fillcolor = white]\\n  tab4 [label = \\\"Generalized\\\", fillcolor = white]\\n  tab5 [label = \\\"MRI, MEG, PET, SPECT\\\", fillcolor = white, shape = ellipse]\\n  tab6 [label = \\\"Lesional with concordant data\\\", fillcolor = white]\\n  tab7 [label = \\\"Non-lesional or lesional near eloquent cortex\\\", fillcolor = white]\\n  tab8 [label = \\\"Consider direct to resection\\\", fillcolor = white]\\n  tab9 [label = \\\"SEEG\\\", fillcolor = white, shape = ellipse]\\n  tab10 [label = \\\"Resection or LITT\\\", fillcolor = white]\\n  tab11 [label = \\\"No resection\\\", fillcolor = white]\\n  tab12 [label = \\\"Neuromodulation/Palliative\\\", fillcolor = white]\\n\\n  # Edge definitions with the node IDs\\n  tab1 -> tab2;\\n  tab2 -> tab3;\\n  tab2 -> tab4;\\n  tab3 -> tab5;\\n  tab5 -> tab6;\\n  tab5 -> tab7;\\n  tab6 -> tab8;\\n  tab7 -> tab9;\\n  tab9 -> tab10;\\n  tab9 -> tab11;\\n  tab11 -> tab12;\\n}\",\"config\":{\"engine\":\"dot\",\"options\":null}},\"evals\":[],\"jsHooks\":[]}</script>\n```\n\n:::\n:::\n\n\n# What are the indications for imaging?\n\n## Indications for Structural Neuroimaging [@gaillard_etal2009] {.smaller}\n\n| Imaging Indicated                                     | Imaging not indicated                                      |\n|----------------------------------------|--------------------------------|\n| Focal history, abnormal exam, focal EEG abnormalities | Childhood absence epilepsy                                 |\n| Developmental regression                              | Juvenile absence epilepsy                                  |\n| \\<2 yrs old                                           | Juvenile myoclonic epilepsy                                |\n| Symptomatic generalized epilepsy syndrome             | SeLECTs (Self-limited epilepsy with centrotemporal spikes) |\n| Increased ICP                                         |                                                            |\n| Status epilepticus                                    |                                                            |\n| Atypical course of SeLECTs or IGE                     |                                                            |\n\n\n::: notes\nILAE subcommittee for pediatric neuroimaging\n:::\n\n## What is the yield of imaging?\n\n-   New onset seizure and status epilepticus 64/177 children (36%) [@lyons.etal2016]\n-   Community-based study in Conneticut of children with new onset epilepsy. 488/613 (79.6%) had imaging. Etiologically relevant findings in 62/488 (12.7%) [@berg.etal2000]\n-   Abnormal exam or focal EEG increases odds of finding abnormality\n\n# Which sequences to use?\n\n## Recommended protocol\n\n![](bernasconi.png)\n\n::: notes\nThe Neuroimaging Task Force recommends use of the Harmonized Neuroimaging of Epilepsy Structural Sequences (HARNESS-MRI) protocol with isotropic, millimetric 3D T1 and FLAIR images, and high-resolution 2D submillimetric T2 images\n:::\n\n## HARNESS-MRI [^5]\n\n[^5]: @bernasconi_etal2019\n\n![](harness.jpg)\n## Another slide here for corontal T2\n\n# Overview of imaging findings in pediatric epilepsy {.smaller}\n\n## Outline\n\n-   Malformations of Cortical Development\n-   Sequelae of perinatal insult\n-   Mesial temporal sclerosis\n-   Autoimmune encephalitis & Rasmussen Encephalitis\n-   Tumors\n-   Vascular malformations\n-   CNS infections\n-   Neurocutaneous syndromes\n\n# Malformations of Cortical Development\n\n## The human brain is a clonal mosaic\n\n![](brain_clonal.webp)\n\n::: notes\nAfter fertilization, the zygote divides to reach the eight-cell stage. Sublineages derived from these first eight progenitors of the human embryo differentiate into ectoderm and, subsequently, contribute asymmetrically to the brain, with some lineages contributing more (for example, red clone) and others contributing much less (for example, yellow and pink clones)\n:::\n\n## Timing is everything...\n\n![](spectrum_mosaic.webp)\n\n\n# Focal Cortical Dysplasia (FCD)\n\n## FCD Classification\n\n![](fcd_chart.png)\n\n[@baldassari.baulac]\n\n## Classification Update {.smaller}\n\n::: columns\n::: column\n- New terms\n  - mild malformations of cortical development (mMCD)\n  - mMCD with oligodendroglial hypertrophy (MOGHE)\n  - \"no definite FCD on histopathology\"\n- \"Layers\" of classification: histopathology, molecular/genetic, imaging (e.g. \"MRI positive Focal Cortical Dysplasia IIb, FCD gene panel negative\")\n:::\n::: column\n![](fcd_class.jpg){height=300px}\n:::\n:::\n\n## FCD Histology\n![](fcd_spectrum.jpeg){height=600px} \n[@najm.etal2022]\n\n::: notes\nStaining with neuronal nuclear antibodies (NeuN). B, FCDIa = abundant neuronal microcolumns with often small neurons vertically arrayed like parallel strings of pearls. C, FCDIb of the temporal lobe without any layered neocortical organization. Also note the dramatically thinned cortical diameter. D, FCDIIb of the frontal lobe is characterized by lack of any cortical layering. Instead, large dysmorphic neurons appear randomly placed throughout the cortical ribbon (arrow). Balloon cells are not visible in this NeuN immunohistochemistry. E, FCDIIIa in the temporal neocortex of a patient with hippocampal sclerosis. Note the neuronal cell loss in supragranular layers L2 and L3 (arrow). F, FCDIIIc in a patient with Sturge–Weber syndrome and a vascular malformation (VM), that is, meningeal angiomatosis. The adjacent neocortex is thin and shows abundant microcolumns (as in FCDIa). G, FCDIIId of the parietofrontal region in a patient with perinatal stroke. Note the patchy disruption of cortical layers (arrow). H, FCDIIId of the occipital region in a boy with perinatal hypoxemic injury. Note the loss of layer 4 neurons (arrow). Scale bar = 500 μm, applies to all images\n:::\n\n## FCD Imaging\n\n- blurring of the gray-white matter interface\n- signal change on T2-weighted and FLAIR images\n  - may indicate presence of balloon cells [@widdess-walsh.etal2006]\n- abnormal thickness or gyration/sulcation patterns\n\n\n## Bottom of Sulcus Dysplasia\n\n## Transmantle sign\nSuggestive of FCD 2B\n\n## Black Line Sign\n\n# Hemimegalencephaly\n\n## Hemimegalencephaly\n\n- rare hamartomatous malformation of the brain with extreme asymmetry\n- classification: isolated, syndromic, and total\n- syndromic associations: epidermal nevus syndrome, Klippel-Trénaunay-Weber syndrome, Proteus syndrome, Hypomelanosis of Ito, Neurofibromatosis, Tuberous Sclerosis, and others \n\n## Hemimegalencephaly - Imaging\n\n- increase in the volume of WM, thick cortex with poor gray-white differentiation \n- May have elements of lissencephaly, pachygyria, polymicrogyria, schizencephaly\n- corpus callosum is usually asymmetric, but may be hypoplastic or absent\n\n\n::: notes\nisoalted = sporadic without associated body hypertrophy, or cutaneous/systemic involvement; total = there is also enlargement of the ipsilateral half of the brainstem and cerebellum (rarest)\n:::\n\n## Total Hemimegalencephaly\n![](hemimegalencephaly-3.jpg){height=300px}\n![](hemimegalencephaly-2.jpg){height=300px}\n![](hemimegalencephaly.jpg){height=300px}\n\nCase courtesy of Frank Gaillard, [Radiopaedia.org, rID: 6619](https://radiopaedia.org/cases/hemimegalencephaly#image-26368)\n\n\n\n\n# Sequelae Perinatal Insults\n\n# Mesial Temporal Sclerosis\n\n# Autoimmune Encephalitis & Rasmussen Encephalitis\n\n# Tumors & Tumor-like conditions\n\n# Vascular malformations\n\n# CNS Infections\n\n## Neurocutaneous syndromes\n\n-   Tuberous sclerosis complex\n-   Sturge Weber syndrome\n-   Less common - hypomelanosis of Ito, epidermal nevus syndrome, Wyburn-Mason syndrome, incontinentia pigmenti\n\n# TSC\n\n## Tuberous Sclerosis Complex {.smaller}\n\n-   Rare monogenic neurocutaneous syndrome due to mutations in *TSC1* or *TSC2*, tumor suppressor genes in the mTOR pathway\n-   Abnormalities on brain MRI in \\>95% TSC patients[@Russo_etal2020]\n-   4 major TSC-related manifestations on neuroimaging:\n\n1.  cortical tubers\n2.  white matter lesions\n3.  sub-ependymal nodules\n4.  sub-ependymal giant cell astrocytomas\n\n-   More rarely, can have intra-parenchymal calcifications, hemimegalencephaly, cerebral or cerebellar malformations, intracranial aneurysms and occlusive vascular disorders.\n\n## Subcortical Tubers in TSC\n\n::: columns\n::: {.column width=\"60%\"}\n-   Glioneuronal brain hemartomas\n-   disrupted 6-layer organization of the cortex\n-   usually frontal or parietal but can be spread in all lobes\n-   Can be *under-recognized* in first years of life due to similarity with adjacent unmyelinated WM\n:::\n\n::: {.column width=\"40%\"}\n![](subcortical-tubers.jpg)[^6]\n:::\n:::\n\n[^6]: Case courtesy of Behrang Amini, Radiopaedia.org, rID: 35867\n\n## Different types of cortical tubers\n\n-   \n\n## Subependymal giant cell astrocytomas (SGCA)\n\n## Sturge Weber syndrome\n\n## Hypomelanosis of Ito\n\n## Take-home points\n\n-   Indications for imaging in pediatric epilepsy\n-   Standardized protocol for MRI\n-   Overview of imaging findings for common and not so common entities in pediatric epilepsy\n\n## References {.scrollable}\n",
    "supporting": [
      "MR-LEC-RevealJS_files"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {
      "include-in-header": [
        "<link href=\"MR-LEC-RevealJS_files/libs/htmltools-fill-0.5.8.1/fill.css\" rel=\"stylesheet\" />\n<script src=\"MR-LEC-RevealJS_files/libs/htmlwidgets-1.6.4/htmlwidgets.js\"></script>\n<script src=\"MR-LEC-RevealJS_files/libs/viz-1.8.2/viz.js\"></script>\n<link href=\"MR-LEC-RevealJS_files/libs/DiagrammeR-styles-0.2/styles.css\" rel=\"stylesheet\" />\n<script src=\"MR-LEC-RevealJS_files/libs/grViz-binding-1.0.11/grViz.js\"></script>\n"
      ],
      "include-after-body": [
        "\n<script>\n  // htmlwidgets need to know to resize themselves when slides are shown/hidden.\n  // Fire the \"slideenter\" event (handled by htmlwidgets.js) when the current\n  // slide changes (different for each slide format).\n  (function () {\n    // dispatch for htmlwidgets\n    function fireSlideEnter() {\n      const event = window.document.createEvent(\"Event\");\n      event.initEvent(\"slideenter\", true, true);\n      window.document.dispatchEvent(event);\n    }\n\n    function fireSlideChanged(previousSlide, currentSlide) {\n      fireSlideEnter();\n\n      // dispatch for shiny\n      if (window.jQuery) {\n        if (previousSlide) {\n          window.jQuery(previousSlide).trigger(\"hidden\");\n        }\n        if (currentSlide) {\n          window.jQuery(currentSlide).trigger(\"shown\");\n        }\n      }\n    }\n\n    // hookup for slidy\n    if (window.w3c_slidy) {\n      window.w3c_slidy.add_observer(function (slide_num) {\n        // slide_num starts at position 1\n        fireSlideChanged(null, w3c_slidy.slides[slide_num - 1]);\n      });\n    }\n\n  })();\n</script>\n\n"
      ]
    },
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}